Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by: Macleods Pharmaceuticals Ltd...
Subpotent Drug
Class IIReported ongoing
Distribution: Nationwide
Home / Brand archive
2 reported ongoing
17 records in this archive. Latest source date Feb 26, 2026.
FDA enforcement status can lag behind the recall lifecycle. An empty search or a reported termination is not a personal product-safety determination.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
Subpotent Drug
Class IIReported ongoing
Distribution: Nationwide
Presence of foreign substance: plastic-like substance.
Class IIReported ongoing
Distribution: USA Nationwide
Mismatching of the embossing on the tablets (T7) with the embossing mentioned in the package insert (ML63) in the distributed bottles.
Class IIIReported terminated
Distribution: Nationwide within United States and Puerto Rico.
Shortfill: customer complaints of one to three tablets were reported missing from 30 count bottles.
Class IIReported terminated
Distribution: Distributed Nationwide and Puerto Rico.
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Class IIReported terminated
Distribution: Product was distributed nationwide.
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Class IIReported terminated
Distribution: Product was distributed nationwide.
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Class IIReported terminated
Distribution: Product was distributed nationwide.
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Class IIReported terminated
Distribution: Product was distributed nationwide.
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Class IIReported terminated
Distribution: Product was distributed nationwide.
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Class IIReported terminated
Distribution: Product was distributed nationwide.
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Class IIReported terminated
Distribution: Product was distributed nationwide.
FAILED CONTENT UNIFORMITY SPECIFICATIONS
Class IIIReported terminated
Distribution: USA Nationwide
cGmp Deviations
Class IIReported terminated
Distribution: Nationwide within the United States
cGMP deviations
Class IIReported terminated
Distribution: USA Nationwide
Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.
Class IIIReported terminated
Distribution: Nationwide within the United States
Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.
Class IIIReported terminated
Distribution: Nationwide within the United States
Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.
Class IIIReported terminated
Distribution: Nationwide within the United States
These examples come from this result page and are not a ranking of every recall reason.
This archive contains 17 records, including 2 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product.
Compare the product, firm and lot, date, model or serial identifiers with the notice. Use the label-check guide if you need help locating an identifier.
A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall.
This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. Check source coverage and the agency's current notices.
Use monthly archives or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page.